scholarly journals Integrating electrical field maps and alcohol cue-reactivity patterns to improve TMS treatment outcome in Alcohol Use Disorder: a retrospective analysis

2021 ◽  
Vol 14 (6) ◽  
pp. 1623-1624
Author(s):  
Daniel McCalley ◽  
Julia Imperatore ◽  
Ingrid Contreras ◽  
Josh Smith ◽  
Sarah Book ◽  
...  
2019 ◽  
Author(s):  
P Halli ◽  
MF Gerchen ◽  
F Kiefer ◽  
P Kirsch

Author(s):  
Patrick Bach ◽  
Georg Weil ◽  
Enrico Pompili ◽  
Sabine Hoffmann ◽  
Derik Hermann ◽  
...  

AbstractPharmacological treatment in alcohol use disorder suffers from modest effect sizes. Efforts have been undertaken to identify patient characteristics that help to select individuals that benefit from pharmacological treatment. Previous studies indicated that neural alcohol cue-reactivity (CR) might provide a marker that identifies patients, which benefit from naltrexone treatment.We investigated the reproducibility of the association between ventral striatum (VS) activation and naltrexone (NTX) treatment response by analyzing data from a recent longitudinal clinical trial in N = 44 abstinent treatment-seeking alcohol-dependent patients. A follow-up was conducted over 3 months. We computed the percentage of significant voxels in VS and tested main effects and interactions with NTX treatment on relapse risk using Cox Regression models.We found a significant interaction effect between pre-treatment cue reactivity in the VS and NTX treatment on time to first heavy relapse (Hazard Ratio = 7.406, 95% CI 1.17–46.56, p = 0.033), such that the patient group with high VS activation (defined by a mean split) showed a significant medication effect (Hazard Ratio = 0.140, 95% CI 0.02–0.75, p = 0.022) with a number needed to treat of 3.4 [95% CI 2.413.5], while there was no significant effect in the group with low VS activation (Hazard Ratio = 0.726, p = 0.454).Thus, using an independent sample we replicated the previously described positive association between VS activation and NTX efficacy. Although our results should be considered cautiously in light of the small sample size, our results support the potential of neural alcohol CR as a tool for precision medicine approaches in alcohol dependence.


2018 ◽  
Vol 76 ◽  
pp. 122-128 ◽  
Author(s):  
Yifrah Kaminer ◽  
Christine McCauley Ohannessian ◽  
James R. McKay ◽  
Rebecca H. Burke ◽  
Kaitlin Flannery

2020 ◽  
Author(s):  
Shou Fukushima ◽  
Hironori Kuga ◽  
Naoya Oribe ◽  
Takeo Mutou ◽  
Takefumi Yuzuriha ◽  
...  

AbstractPatients with alcohol use disorder (AUD) have difficulties controlling alcohol cravings and thus exhibit increased use and earlier relapse. Although patients tend to respond more strongly to alcohol-related images compared with non-alcohol-related images, few researchers examined the factors that modulate cravings. Here, we examined whole-brain blood oxygen level-dependent (BOLD) responses to behavioural cues in individuals with AUD and healthy controls (HCs). The participants included 24 patients with severe AUD and 15 HCs. We presented four beverage images (juice, drinking juice, sake, and drinking sake) and compared participant BOLD responses between the two groups. Multiple comparisons revealed that the AUD group had lower BOLD responses compared with the HC group to images of drinking juice in the left precuneus (p = 0.036) and the left posterior cingulate cortex (PCC) (p = 0.044) and higher BOLD responses to images of drinking sake in the left PCC (p = 0.044). Furthermore, compared to the HCs, the AUD patients had decreased BOLD responses associated with cue reactivity to drinking juice in the left precuneus during the period from 15 to 18 s (p = 0.004, df = 37) and 18 to 21 s (p = 0.002, df = 37). Using the Spearman correlation, we found a significant negative correlation between BOLD responses in the left PCC of the AUD patients and Mini–Mental State Examination (MMSE) scores (r = −0.619, p = 0.001). Our findings suggest that HCs and severe AUD patients differ in their responses not to images of alcoholic beverages but those related to alcohol drinking behavior. Thus, these patients appear to have different patterns of brain activity. This information may aid clinicians in developing treatments for patients with AUD.


2020 ◽  
Vol 237 (6) ◽  
pp. 1691-1707
Author(s):  
S Vollstädt-Klein ◽  
S Gerhardt ◽  
A Lee ◽  
A Strosche ◽  
G Sharafi ◽  
...  

PLoS ONE ◽  
2020 ◽  
Vol 15 (7) ◽  
pp. e0229187 ◽  
Author(s):  
Shou Fukushima ◽  
Hironori Kuga ◽  
Naoya Oribe ◽  
Takeo Mutou ◽  
Takefumi Yuzuriha ◽  
...  

PLoS ONE ◽  
2020 ◽  
Vol 15 (11) ◽  
pp. e0242531
Author(s):  
Shou Fukushima ◽  
Hironori Kuga ◽  
Naoya Oribe ◽  
Takeo Mutou ◽  
Takefumi Yuzuriha ◽  
...  

2019 ◽  
Vol 43 (12) ◽  
pp. 2637-2648 ◽  
Author(s):  
Paul R. Stasiewicz ◽  
Clara M. Bradizza ◽  
Melanie U. Ruszczyk ◽  
Joseph F. Lucke ◽  
Junru Zhao ◽  
...  

Author(s):  
Reagan R. Wetherill ◽  
Nathaniel Spilka ◽  
Kanchana Jagannathan ◽  
Paige Morris ◽  
Danielle Romer ◽  
...  

AbstractTopiramate, a GABA/glutamate modulator, is efficacious in reducing alcohol consumption, though the mechanisms underlying this effect are not well characterized. This study analyzed functional magnetic resonance imaging (fMRI) data from 22 heavy drinkers enrolled in a 12-week placebo-controlled, randomized clinical trial of topiramate to examine the effects of topiramate on alcohol cue-elicited brain responses, craving, and heavy drinking in individuals with DSM-5 alcohol use disorder. Patients were randomized to receive either topiramate (maximal daily dosage of 200 mg/day) or placebo and were administered an fMRI alcohol cue-reactivity task at baseline (before starting medication) and after 6 weeks of double-blind treatment. Analyses compared the topiramate (n = 12) and placebo (n = 8) groups on (1) the change in brain responses during alcohol cue exposure (vs non-alcohol cues) within five a priori regions of interest related to reward—the bilateral and medial orbitofrontal cortex (OFC) and bilateral ventral striatum (VS) and (2) change in craving and heavy drinking days (HDDs) from baseline and scan 2. Topiramate, relative to placebo, reduced alcohol cue-elicited activation of the left VS, bilateral OFC, and medial OFC, alcohol cue-elicited craving, and HDDs between baseline and 6 weeks of treatment. The reduction in alcohol cue-elicited activation in the medial OFC correlated with reductions in craving, and reduced activation in the right VS, right OFC, and medial OFC correlated with the reduction in HDD. This preliminary study provides evidence that topiramate’s attenuation of alcohol cue-elicited brain activation and craving are key elements of the drug’s neurobiological mechanism of action in reducing heavy drinking.


2014 ◽  
Vol 140 ◽  
pp. e61
Author(s):  
B. Fleury ◽  
Cecile M. Denis ◽  
B. Nalpas ◽  
M. Crapelet ◽  
Marc Auriacombe

Sign in / Sign up

Export Citation Format

Share Document